Table 4 Clinical characteristics of PH patients where we used iNO and /or PS.
Variable | iNO + PS (n = 14) | Only iNO (n = 6) | Only PS (n = 16) | No iNO and PS (n = 20) | P-value |
---|---|---|---|---|---|
Age | 29.2 ± 2.6 | 29.5 ± 2.2 | 27.7 ± 2.1 | 28.6 ± 1.7 | 0.19 |
Gender(male/female) | 7/7 | 5/1 | 4/12 | 14/6 | 0.02 |
Weight, (mean ± SD g) | 1211 ± 406 | 1325 ± 419 | 1010 ± 294 | 1121 ± 222 | 0.21 |
Apgar 1 min, (median, quartile) | 5.5 (3.7,8) | 7 (3,8) | 6 (4,7) | 7.5 (5,9) | 0.28 |
Apgar 5 min, (median, quartile) | 7.5 (7,9) | 9 (6.7,9.2) | 8 (7.2,9) | 9 (8,9.75) | 0.41 |
ABG PH 1 h after birth, (mean ± SD) | 7.240 ± 0.085 | 7.176 ± 0.172 | 7.235 ± 0.083 | 7.292 ± 0.097 | 0.06 |
Cesarean, n (%) | 8 (57.1) | 4 (66.7) | 13 (81.3) | 10 (50.0) | 0.27 |
Twin, n (%) | 5 (35.7) | 0 | 8 (50.0) | 5 (25.0) | 0.13 |
SGA, n (%) | 3 (21.4) | 0 | 1 (6.3) | 2 (10.0) | 0.43 |
PROM, n (%) | 4 (28.6) | 1 (16.7) | 1 (6.3) | 5 (25.0) | 0.40 |
GDM, n (%) | 0 | 0 | 0 | 0 | – |
Abortion history, n (%) | 7 (50.0) | 1 (16.7) | 7 (43.8) | 7 (35.0) | 0.52 |
RDS, n (%) | 11 (78.6) | 3 (50) | 12 (75.0) | 5 (25.0) | 0.004 |
PIH, n (%) | 2 (14.3) | 1 (16.7) | 4 (25.0) | 1 (5.0) | 0.40 |
EOS, n (%) | 11 (78.6) | 5 (83.3) | 5 (31.3) | 9 (45.0) | 0.02 |
PDA, n (%) | 9 (64.3) | 2 (33.3) | 8 (50.0) | 7 (35.0) | 0.34 |
Pneumothorax, n (%) | 1 (7.1) | 1 (16.7) | 3 (18.8) | 0 | 0.23 |
MAS, n (%) | 1 (7.1) | 1 (16.7) | 0 | 1 (5.0) | 0.47 |
Before treatment P/F ratio, (mean ± SD) | 129.6 ± 47.9 | 160.8 ± 123.8 | 114.8 ± 48.2 | 133 ± 49.54 | 0.63 |
24 h After treatment P/F ratio, (mean ± SD) | 238.4 ± 76.4 | 317 ± 111.1 | 271.9 ± 124.0 | 280.5 ± 66.4 | 0.45 |
Mechanical ventilation, n (%) | 13 (92.9) | 6 (100) | 15 (93.8) | 15 (75.0) | 0.19 |
Sildenafil, n (%) | 5 (35.7) | 5 (83.3) | 7 (43.8) | 12 (60.0) | 0.19 |
Milrinone, n (%) | 9 (64.3) | 3 (50.0) | 4 (25.0) | 6 (30.0) | 0.11 |
Vasoconstrictive drugs, n (%) | 3 (21.4) | 5 (83.3) | 9 (56.3) | 8 (40.0) | 0.05 |
BPD, n (%) | 2 (14.3) | 1 (16.7) | 7 (43.8) | 16 (80.0) | 0.001 |
ROP, n (%) | 2 (14.3) | 1 (16.7) | 4 (25) | 4 (20.0) | 0.90 |
IVH, n (%) | 3 (21.4) | 1 (16.7) | 3 (18.8) | 6 (30.0) | 0.83 |
NEC, n (%) | 1 (7.1) | 0 | 2 (12.5) | 1 (5.0) | 0.73 |
Death, n (%) | 0 | 0 | 0 | 0 | – |